Evidence-Based Medicine Guidelines
Ipratropium bromide added to beta2-agonists in acute childhood asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ipratropium Bromide Added to Beta2-agonists in Acute Childhood Asthma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451187/all/Ipratropium_bromide_added_to_beta2_agonists_in_acute_childhood_asthma.
Ipratropium bromide added to beta2-agonists in acute childhood asthma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451187/all/Ipratropium_bromide_added_to_beta2_agonists_in_acute_childhood_asthma. Accessed April 21, 2025.
Ipratropium bromide added to beta2-agonists in acute childhood asthma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451187/all/Ipratropium_bromide_added_to_beta2_agonists_in_acute_childhood_asthma
Ipratropium Bromide Added to Beta2-agonists in Acute Childhood Asthma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451187/all/Ipratropium_bromide_added_to_beta2_agonists_in_acute_childhood_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ipratropium bromide added to beta2-agonists in acute childhood asthma
ID - 451187
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451187/all/Ipratropium_bromide_added_to_beta2_agonists_in_acute_childhood_asthma
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
